National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars’ ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

The West Virginia Board of Education voted at its monthly meeting Wednesday to send a letter to the Professional Charter ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs,supporting potential for improved protection against infection ...

With Kennedy leading HHS, this about-face is easy to parse as yet another anti-vaccine move. But the assault on mRNA is also ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Health Secretary Robert F. Kennedy Jr.’s cut to funding for mRNA research will also hurt the nation’s reputation as a leader ...